Skip to content

Insider · CIK 0001878692

Neil Desai

directorchairofficer

Files at WHWK (Aadi Bioscience, Inc.). First filing Nov 2, 2023, latest Dec 7, 2023.

In brief

Neil Desai files SEC Form 4 as director and chair at WHWK (Aadi Bioscience, Inc.). Since Nov 2, 2023, Neil Desai has reported 0 open-market buys worth $0 and 3 open-market sells worth $397k, the latest filed on Dec 7, 2023.

A track record needs three past buys with six months of prices behind them; Neil Desai has 0, so none is measured yet.

The newest scored trade: sold $34k of WHWK on Dec 6, 2023, filed Dec 7, 2023, scored 6 (weak), under a 10b5-1 plan.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $397k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

WHWK: Aadi Bioscience, Inc.

WHWKOct 9, 2026 · close 3.52

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
6Weak
WHWKsell10b5-1
Aadi Bioscience, Inc.
$34k
7,037 shares
-0%+20% from low-65% from high
12Weak
WHWKsell10b5-1
Aadi Bioscience, Inc.
$178k
34,963 shares
-2%+27% from low-63% from high
12Weak
WHWKsell10b5-1
Aadi Bioscience, Inc.
$186k
42,000 shares
-3%+10% from low-68% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Dec 1, 2023 WHWK
Aadi Bioscience, Inc.
126,000
0.51% of outstanding
$668kDec 1, 2023$521k

Transactions

Every row this insider has filed, 8 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 12, 2026WHWK
Aadi Bioscience, Inc.
AGrant or award
Stock Option (right to buy)derivative
+38,040$0.00$038,040Jun 15, 2026
Jun 12, 2025WHWK
Aadi Bioscience, Inc.
AGrant or award
Stock Option (right to buy)derivative
+40,006$0.00$040,006Jun 17, 2025
Dec 6, 2023WHWK
Aadi Bioscience, Inc.
SOpen-market sale
Common Stockindirect: See footnote10b5-1
-7,037$4.82$34k1,537,543Dec 7, 2023
Dec 1, 2023WHWK
Aadi Bioscience, Inc.
SOpen-market sale
Common Stockindirect: See footnote10b5-1
-8,347$5.14$43k1,571,196Dec 5, 2023
Dec 4, 2023WHWK
Aadi Bioscience, Inc.
SOpen-market sale
Common Stockindirect: See footnote10b5-1
-10,876$5.15$56k1,560,320Dec 5, 2023
Dec 5, 2023WHWK
Aadi Bioscience, Inc.
SOpen-market sale
Common Stockindirect: See footnote10b5-1
-15,740$5.02$79k1,544,580Dec 5, 2023
Nov 1, 2023WHWK
Aadi Bioscience, Inc.
SOpen-market sale
Common Stockindirect: See footnote10b5-1
-10,338$4.32$45k1,611,205Nov 2, 2023
Nov 2, 2023WHWK
Aadi Bioscience, Inc.
SOpen-market sale
Common Stockindirect: See footnote10b5-1
-31,662$4.46$141k1,579,543Nov 2, 2023

Questions about Neil Desai

Answered from the filings on this page, as of the latest one.

Is Neil Desai buying or selling?

Not in the last 12 months. Neil Desai's latest open-market trade on SEC Form 4 was sold $34k of WHWK on Dec 6, 2023.

How did Neil Desai's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Neil Desai has 0.

Where does Neil Desai file Form 4?

Neil Desai has filed Form 4 at WHWK (Aadi Bioscience, Inc.) as Executive Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Neil Desai: insider trades and track record | InsiderTell